#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13208	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2274	576.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1579	1579	C	755	C,A	725,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13208	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2274	576.8	0	HET	.	.	.	C207T	.	207	207	C	602	602	C	727	C,T	564,129	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13208	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2274	576.8	0	HET	.	.	.	C451T	.	451	451	C	846	846	C	759	C,T	366,368	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24116	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3546	676.1	0	.	n	.	0	T695C	SNP	695	695	T	1031	1031	C	730	C	708	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24116	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3546	676.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1974	1974	G	754	G,A	307,421	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24116	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3546	676.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2307	2307	C	731	C	698	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24116	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3546	676.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2381	2381	A	707	A	688	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24116	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3546	676.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2933	2933	C	765	C	739	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1392	folP	855	855	100.0	folP.l6.c30.ctg.1	1636	84.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1093	1095	AGC	151;152;149	A;G;C,T	145;148;145,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4086	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3359	120.4	1	SNP	p	S91F	1	.	.	271	273	TTC	518	520	TTC	151;149;149	T;T;C	144;142;140	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4086	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3359	120.4	1	SNP	p	G95N	0	.	.	283	285	GGC	530	532	GGC	146;143;143	G;G;C	137;136;137	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4086	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3359	120.4	1	SNP	p	D95G	1	.	.	283	285	GGC	530	532	GGC	146;143;143	G;G;C	137;136;137	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1286	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1239	102.2	1	SNP	p	G45D	0	.	.	133	135	GGC	436	438	GGC	172;170;169	G;G;C	167;165;164	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	626	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1051	59.3	0	.	n	.	0	A197.	DEL	197	197	A	659	659	A	138	A	134	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	160.0	1	SNP	p	D86N	0	.	.	256	258	GAC	549	551	GAC	191;190;191	G;A,G;C	186;184,1;189	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	160.0	1	SNP	p	S87R	1	.	.	259	261	CGT	552	554	CGT	190;188;191	C;G;T	190;188;185	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	160.0	1	SNP	p	R87W	0	.	.	259	261	CGT	552	554	CGT	190;188;191	C;G;T	190;188;185	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	160.0	1	SNP	p	R87I	0	.	.	259	261	CGT	552	554	CGT	190;188;191	C;G;T	190;188;185	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	160.0	1	SNP	p	S88P	0	.	.	262	264	TCC	555	557	TCC	191;188;188	T;C;C	190;185;187	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3176	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2679	117.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	138;138;134	G;G;C	134;131;131	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1298	1300	GCC	166;166;165	G;C,G;C	160;163,1;158	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1301	1303	ATG	162;162;163	A;T;G	160;157;157	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1313	1315	ACC	163;162;164	A;C;C	154;159;160	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1313	1315	ACC	163;162;164	A;C;C	154;159;160	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1814	1816	ACC	162;163;164	A;C;C	151;154;155	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1868	1870	GCG	153;151;151	G;C;G	150;147;147	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1868	1870	GCG	153;151;151	G;C;G	150;147;147	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1991	1993	GGT	107;103;102	G;G;T	105;101;97	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2000	2002	AGC	98;97;95	A;G;C	93;92;90	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3200	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2446	129.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2018	2020	CCG	94;101;93	C;CG,CGG;G	88;85,1;80	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5090	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3162	160.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1693	1695	CCG	171;170;171	C;C;G,C	161;161;157,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2068	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2073	99.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	597	597	C	136	C	127	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	232	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1142	17.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	879	881	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	232	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1142	17.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	882	884	AAT	9;9;9	A;A;T	9;9;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	232	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1142	17.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	906	908	GCA	9;9;8	G;C;A	9;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	232	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1142	17.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	929	931	GTA	8;8;8	G;T;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	232	porB1a	984	287	91.07	porB1a.l15.c30.ctg.1	1142	17.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	938	938	A	9	A	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1547	182.1	1	SNP	p	G120K	1	.	.	358	360	AAG	632	634	AAG	233;231;231	A;A;G	221;222;219	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1547	182.1	1	SNP	p	N121D	0	.	.	361	363	AAC	635	637	AAC	230;232;234	A;A;C	217;218;219	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2850	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1547	182.1	1	SNP	p	A121N	1	.	.	361	363	AAC	635	637	AAC	230;232;234	A;A;C	217;218;219	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9524	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4852	195.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1162	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1192	96.5	1	SNP	p	V57M	1	.	.	169	171	ATG	618	620	ATG	234;232;234	A;T;G	226;225;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
